HIPAA Alert: Potential Data Breach Learn More

Search
Close this search box.

Bone Marrow Transplant

Bone Marrow Transplant

We’re here for you. Call us at 844-346-7222 or

find a clinical trial

If you have any questions or are interested in participating in one of our Clinical Trials, please take note of the associated protocol number and contact our team at (201) 518-3587, or email us at email.

30 Clinical Trials
Bone Marrow Transplant N/A Enrolling
nct/study# NCT05776160 / KT-US-471-0140

Expanded Access Study for the Treatment of Patients with Commercially Out-of-Specification Axicabtagene Ciloleucel

Learn More
Bone Marrow Transplant N/A Enrolling
nct/study# NCT05776134 / KT-US-472-0141

Expanded Access Study for the Treatment of Patients with Commercially Out-of-Specification Brexucabtagene Autoleucel

Learn More
Bone Marrow Transplant Phase II Enrolling
nct/study# NCT03601442 / MAP-PRO2018-0751

Managed Access Program (MAP) to Provide Access to CTL019, for ALL or DLBCL Patients With Out of Specification Leukapheresis Product and/or Manufactured Tisagenlecleucel Out of Specification for Commercial Release

Learn More
Bone Marrow Transplant N/A Enrolling
nct/study# N/A / MSK-19-373

MSK Outcomes of patients treated with CAR T cells

Learn More
Bone Marrow Transplant N/A Enrolling
nct/study# N/A / MYELOFIBROSIS-CHIMERISMS

Post-Transplant Chimerism Patterns in Patients with Myelodysplastic Syndromes and Myelofibrosis Undergoing Allogeneic Hematopoietic Stem Cell Transplantation at the John Theurer Cancer Center

Learn More
Bone Marrow Transplant N/A Enrolling
nct/study# N/A / NGS-AML-ALLO

Dynamic Changes in Pre- and Post-Transplant NGS MRD Status For Prediction of the Allogeneic Stem Cell Transplant Outcome in Patients with AML

Learn More

We are here for you

For more information or to schedule an appointment, call (844) 346-7222. You can also schedule an appointment by calling the RCCA location nearest you.

Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.